Navigation Links
Zeuba Vital Elbow Support

ProductsZeuba Vital Elbow Support
Company Bauerfeind USA, Inc.
Item Zeuba Vital Elbow Support
Features 
  • Wrap-around support stabilizes the elbow and reduces pain caused by repetitive movements
  • Highly elastic knit allows skin to breathe and equalizes temperature
  • Compression increases circulation to invigorate the arm muscles
  • Precise three-point massage relieves aching muscles and increases power
  • Improves muscle coordination to decrease chance of overuse injuries
  • Enhances striking and throwing force
  • Controls directional accuracy and precision
  • Individually adjustable for a perfect fit
  • Stays comfortably in place, even during vigorous activity
  • Machine wash and dry
  • Description The elbow and surrounding muscles are constantly under stress when you move your forearm and wrist. Zeuba Vital Elbow Support provides strength and a precise massage to invigorate arm muscles.
    Info Bauerfeind USA, Inc.
    Customer Service: 800.423.3405
    Web site: http://www.bauerfeindusa.com/

    Related medicine products :

    1. Zeuba Vital Knee Support
    2. M.R.I. Vital Port Systems (standard size)
    3. Titanium Vital Port Systems (standard size)
    4. Petite Titanium Vital Port Systems
    5. Petite M.R.I. Vital Port Systems
    6. Mini Titanium Vital Port Systems
    7. Dual Chamber M.R.I. Vital Port Systems
    8. Dual Chamber Titanium Vital Port Systems
    9. Petite Dual Chamber Titanium Vital Port Systems
    10. Mini Titanium Vital-Port Systems for Peripheral Placement
    11. Vitality DS
    ...aboratories is a national reference laboratory and...rch and development. ARUP offers an extensive test...n clinical and anatomic pathology. Owned by the Un...de more than half of the nation's university teach...
    ...aboratories is a national reference laboratory and...rch and development. ARUP offers an extensive test...n clinical and anatomic pathology. Owned by the Un...de more than half of the nation's university teach...
    ...aboratories is a national reference laboratory and...rch and development. ARUP offers an extensive test...n clinical and anatomic pathology. Owned by the Un...de more than half of the nation's university teach...
    ...aboratories is a national reference laboratory and...rch and development. ARUP offers an extensive test...n clinical and anatomic pathology. Owned by the Un...de more than half of the nation's university teach...
    Medicine Products:
    (Date:10/8/2008)... a leader in the commercial two-way radio industry...is new technology allows users to talk via two way...or even thousands of miles away! , ...-- Fast Radios, a leader in the commercial two-way...com/roip.html [2-way radios over internet (RoIP) _...
    (Date:10/7/2008)...EMD in North America) announced today the extensio...ra, Inc., a leading nanotechnology co-development ...rmany (Business Wire EON) October 7, 2008 -- The ...d in February 2007, was to develop innovative, nan...Merck,s materials. , , , After successfully meetin...
    (Date:10/7/2008)...-USNewswire/ -- The Ohio Nurses,Association Politi...its,final round of endorsed candidates for the Nov... SD 26 Karen Gillmor (R) Tiffin, Ohio House of R...City;, HD 28 Connie Pillich (D) Cincinnati;, HD ...endorsed candidates for the Ohio General Assembly ...
    (Date:10/7/2008)...s easier to spot , , TUESDAY, Oct. 7 (He...e type of breast cancer in women with an evaluated...make an earlier diagnosis of another form of breas...viously had been shown to reduce the risk of estro...at high risk of the disease, but not to affect the...
    Breaking Medicine News(10 mins):Health News:Fast Radios Introduces RoIP: Extending Two-Way Radio Range Thousands of Miles 2Health News: Merck KGaA and Nano-Terra Announce Extension of Nanotechnology Solutions Alliance 2Health News: Merck KGaA and Nano-Terra Announce Extension of Nanotechnology Solutions Alliance 3Health News:ONA-PCE Announces Final Round of Endorsed Candidates for Ohio General Assembly 2Health News:ONA-PCE Announces Final Round of Endorsed Candidates for Ohio General Assembly 3Health News:Tamoxifen Speeds Diagnosis of ER-Negative Breast Cancer 2
    ...sity of NSW researchers in Australia are conductin...study could answer some questions about aging. // ...ere are vast differences between them,' study lead...'By studying twins, we will be able to better dete...
    ...and vegetable juices may have the unique property ...ding to a new study. //US researchers examined mor... the latest issue of the American Journal of Medic...isk of Alzheimer's was reduced by as much as 76 pe...
    ...s conducted by a researcher from the Institute of ...that human body// is designed to strongly resist a...o prevent weight gain. The findings of the study w...rnational gathering of obesity experts hosted by Q...
    ...-based Center for Disease Control and Prevention (...elbourne-based pharmaceutical development company/...ndidate vaccine developed by BioDiem and its Dutch...in Atlanta, the US government's leading site for r...
    Other Medicine News:Health News:Human Body Designed To Resist Weight Loss 2
    (Date:10/6/2008)...eo clips feature children, parents discussing clin...ESDA, Md., Oct. 6 /PRNewswire-USNewswire/ -- From ... in children saves lives and improves their,health...Institutes of,Health (NIH), "Children and Clinical...nhlbi.nih.gov ), offers parents and health,care pr...
    (Date:10/6/2008)...hase 3b Studies with Durezol Dosed Prior to Surger...rapeutics, Inc., a,privately held ophthalmic-focus... Durezol(TM) (difluprednate ophthalmic emulsion) 0... was approved by the U.S. Food and,Drug Administra...steroid,indicated for the treatment of inflammatio...
    (Date:10/6/2008)...Calif. and SEATTLE, Oct. 6 /- Complet...n human genome sequencing,company, and the Institu...,partnership to conduct populationwide human genom... Genomics will use its proprietary,DNA sequencing ...rovided by,ISB. Then, once proof-of-concept has be...
    (Date:10/6/2008)...kinetic Characteristics of Naltrexone SR Associate...cal Trials -, PHOENIX, Oct. 6 /PRNewswire-FirstCa...), a biopharmaceutical company focused on the trea...related disorders, today presented,data showing th... /,bupropion SR), successfully achieved key object...
    Breaking Medicine Technology:Photos: NIH Launches New Web Site for Parents on Medical Research Studies for Children 2Photos: NIH Launches New Web Site for Parents on Medical Research Studies for Children 3Photos: NIH Launches New Web Site for Parents on Medical Research Studies for Children 4Video: Sirion Therapeutics Launches Durezol for Postoperative Ocular Inflammation and Pain 2Video: Sirion Therapeutics Launches Durezol for Postoperative Ocular Inflammation and Pain 3Video: Sirion Therapeutics Launches Durezol for Postoperative Ocular Inflammation and Pain 4Video: Sirion Therapeutics Launches Durezol for Postoperative Ocular Inflammation and Pain 5Complete Genomics and the Institute for Systems Biology Announce Partnership to Conduct the First Human Genome Population Study 2Orexigen(R) Therapeutics Presents Data on Its Proprietary Formulation of Naltrexone Sustained Release (SR) Used in Contrave(R) 2Orexigen(R) Therapeutics Presents Data on Its Proprietary Formulation of Naltrexone Sustained Release (SR) Used in Contrave(R) 3Orexigen(R) Therapeutics Presents Data on Its Proprietary Formulation of Naltrexone Sustained Release (SR) Used in Contrave(R) 4Orexigen(R) Therapeutics Presents Data on Its Proprietary Formulation of Naltrexone Sustained Release (SR) Used in Contrave(R) 5Chair of Radiology at Presbyterian Hospital of Dallas Named President of American College of Physician Executives 21600 1Chair of Radiology at Presbyterian Hospital of Dallas Named President of American College of Physician Executives 21600 2CVS Caremark Launches the 2008 Season of the CVS Caremark All Kids Can 28TM 29 Baseball Camps at Fenway Park 21598 1CVS Caremark Launches the 2008 Season of the CVS Caremark All Kids Can 28TM 29 Baseball Camps at Fenway Park 21598 2Targeted Anticancer Drugs In Vitro Assessment and Non Invasive Imaging of Patient and Tumor Status Will Determine Clinical and Commercial Success 21596 1Targeted Anticancer Drugs In Vitro Assessment and Non Invasive Imaging of Patient and Tumor Status Will Determine Clinical and Commercial Success 21596 2Targeted Anticancer Drugs In Vitro Assessment and Non Invasive Imaging of Patient and Tumor Status Will Determine Clinical and Commercial Success 21596 3Targeted Anticancer Drugs In Vitro Assessment and Non Invasive Imaging of Patient and Tumor Status Will Determine Clinical and Commercial Success 21596 4Morria Biopharmaceuticals Plc Announces Regulatory Approval to Commence Phase II Clinical Study of MRX 4 in Allergic Rhinitis 2395 1Morria Biopharmaceuticals Plc Announces Regulatory Approval to Commence Phase II Clinical Study of MRX 4 in Allergic Rhinitis 2395 2
    ... Effective in Improving Symptoms and Urine Flow, W...Calif., May 23, 2007 /PRNewswire-FirstCall/ -- Spe... 2 safety and efficacy,data for ozarelix, the Comp...rostatic hypertrophy (BPH), at the American Urolog...onvention Center in,Anaheim, California on Tuesday...
    ... N.J.--(BUSINESS WIRE)--May 23, 2007 - Cytogen,Cor...tion of a,review validating the utility of its Pro...the WW domain-containing oxidoreductase,(WWOX), an...ement,in breast, prostate, lung, pancreatic, esoph...cle was published in the online,edition (25 April ...
    Other Medicine Technology:Ozarelix Phase 2 Data in Benign Prostatic Hypertrophy Presented at,Annual Meeting of American Urological Association 2Ozarelix Phase 2 Data in Benign Prostatic Hypertrophy Presented at,Annual Meeting of American Urological Association 3Ozarelix Phase 2 Data in Benign Prostatic Hypertrophy Presented at,Annual Meeting of American Urological Association 4Ozarelix Phase 2 Data in Benign Prostatic Hypertrophy Presented at,Annual Meeting of American Urological Association 5Cytogen Reports Publication Validating the Utility of its,Proprietary ProChart Database 2Cytogen Reports Publication Validating the Utility of its,Proprietary ProChart Database 3Cytogen Reports Publication Validating the Utility of its,Proprietary ProChart Database 4